Announcements Trials
Browse Landscape

Phase

Phase 2 7Phase 4 3Phase 3 3Phase NA 2Phase 1/2 1

Status

Completed 2Recruiting 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

CNS 3

Conditions

Brain Neoplasms 2Seizures 1Glioma 1Epilepsy 1

Interventions

Dexamethasone 56Metformin 50Cyclophosphamide 47Saline Solution 39Cytarabine 37Cisplatin 37Zoledronic Acid 34Letrozole 34Sodium Chloride 33Carboplatin 33Bupivacaine 31Bevacizumab 31Docetaxel 30Vincristine 29Methotrexate 29Fluorouracil 28Propofol 27Capecitabine 27Fentanyl 26Doxorubicin 26Rituximab 25Drug Therapy 25Dexmedetomidine 25Prednisone 23Paclitaxel 23Gemcitabine 22Oxaliplatin 21Morphine 21Radiotherapy 19Prednisolone 19

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 4 × Interventional × Levetiracetam × Clear all
NCT03048084 2025-02-04

STING

Leiden University Medical Center

Phase 4 Recruiting
120 enrolled
CNS

Glioma

NCT02334722 2021-12-15

1 Week Versus 6 Weeks of Levetiracetam in Surgical Brain Tumor Patients

University of Florida

Phase 4 Completed
81 enrolled 10 charts
CNS

Brain Neoplasms, Seizures

NCT00571155 2009-08-20

Trial of Levetiracetam in Patients With Primary Brain Tumors and Symptomatic Seizures Who Undergo Surgery

University Hospital Tuebingen

Phase 4 Completed
30 enrolled
CNS

Brain Neoplasms, Epilepsy

Data powered by HemOnc (CC BY 4.0) Colophon âš¡